Magellan Health, Inc. (MGLN) Income Statement Analysis

See more : ReposiTrak, Inc. (TRAK) Income Statement Analysis – Financial Results

Complete financial analysis of Magellan Health, Inc. (MGLN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Magellan Health, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.

You may be interested

Shivagrico Implements Limited (SHIVAGR.BO) Income Statement Analysis – Financial Results
Zhen Ding Technology Holding Limited (4958.TW) Income Statement Analysis – Financial Results
Wayland Group Corp. (MRRCF) Income Statement Analysis – Financial Results
SGT German Private Equity GmbH & Co. KGaA (SGF.DE) Income Statement Analysis – Financial Results
Southeastern Banking Corporation (SEBC) Income Statement Analysis – Financial Results

Magellan Health, Inc. (MGLN)

Industry: Medical - Healthcare Plans

Sector: Healthcare

Website: https://www.magellanhealth.com

About Magellan Health, Inc.

Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.

Metric	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994
Revenue	4.58B	7.16B	7.31B	5.84B	4.84B	4.60B	3.76B	3.55B	3.21B	2.80B	2.97B	2.64B	2.63B	2.16B	1.69B	1.81B	1.80B	1.51B	445.89M	1.76B	1.87B	1.87B	1.51B	1.21B	1.35B	1.15B	904.65M
Cost of Revenue	4.46B	6.93B	7.12B	5.57B	4.58B	4.42B	3.55B	3.31B	2.96B	2.02B	2.13B	2.43B	2.44B	1.96B	1.51B	1.57B	0.00	1.32B	0.00	1.56B	1.65B	1.66B	1.29B	978.51M	0.00	0.00	0.00
Gross Profit	118.79M	229.29M	197.18M	271.02M	258.94M	178.38M	215.08M	238.19M	249.58M	782.64M	842.63M	207.46M	186.87M	193.26M	181.90M	241.62M	1.80B	185.86M	445.89M	198.47M	220.97M	208.01M	217.97M	232.18M	1.35B	1.15B	904.65M
Gross Profit Ratio	2.60%	3.20%	2.70%	4.64%	5.35%	3.88%	5.72%	6.72%	7.78%	27.96%	28.38%	7.85%	7.12%	8.96%	10.76%	13.36%	100.00%	12.30%	100.00%	11.31%	11.79%	11.11%	14.41%	19.18%	100.00%	100.00%	100.00%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.59B	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	0.00	0.00	0.00	0.00	876.61M	822.39M	723.50M	619.55M	557.51M	529.63M	566.58M	0.00	0.00	0.00	0.00	15.81M	1.59B	0.00	391.43M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Expenses	98.39M	131.51M	132.66M	115.71M	-770.57M	-719.55M	-632.43M	-547.55M	-497.02M	58.62M	54.68M	47.27M	60.81M	57.52M	48.86M	49.09M	42.49M	358.06M	14.38M	35.07M	91.02M	63.79M	103.54M	163.71M	1.23B	1.15B	922.79M
Operating Expenses	98.39M	131.51M	132.66M	115.71M	106.05M	102.84M	91.07M	71.99M	60.49M	588.26M	621.26M	47.27M	60.81M	57.52M	48.86M	64.90M	1.63B	358.06M	405.81M	35.07M	91.02M	63.79M	103.54M	163.71M	1.23B	1.15B	922.79M
Cost & Expenses	4.56B	7.06B	7.25B	5.68B	4.68B	4.52B	3.64B	3.38B	3.02B	2.61B	2.75B	2.48B	2.50B	2.02B	1.56B	1.63B	1.63B	1.68B	405.81M	1.59B	1.74B	1.73B	1.40B	1.14B	1.23B	1.15B	922.79M
Interest Income	4.05M	19.19M	14.07M	5.89M	2.82M	2.17M	1.30M	1.99M	2.02M	2.78M	3.28M	6.25M	17.03M	23.84M	17.63M	17.46M	6.13M	2.87M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	30.87M	36.15M	35.40M	25.98M	10.19M	6.58M	7.39M	3.00M	2.25M	2.50M	2.23M	2.42M	2.85M	6.39M	7.29M	44.01M	37.12M	61.02M	873.00K	-8.80M	-83.00M	-18.41M	-38.31M	-14.36M	-6.16M	0.00	-12.62M
Depreciation & Amortization	118.75M	131.51M	132.66M	115.71M	106.05M	102.84M	91.07M	71.99M	60.49M	58.62M	54.68M	47.27M	60.81M	57.52M	48.86M	49.09M	42.49M	48.05M	14.38M	70.28M	79.24M	73.53M	54.89M	44.86M	48.92M	64.09M	59.55M
EBITDA	487.41M	248.48M	211.25M	276.97M	263.85M	183.25M	221.55M	240.18M	251.60M	255.79M	279.32M	213.70M	203.90M	216.74M	205.11M	306.09M	214.57M	594.65M	29.24M	131.22M	28.91M	105.60M	55.64M	53.60M	107.00M	9.82M	-10.60M
EBITDA Ratio	10.65%	3.47%	2.89%	4.74%	5.45%	3.99%	5.89%	6.77%	7.84%	9.14%	9.41%	8.09%	7.77%	10.05%	12.13%	16.93%	11.95%	39.36%	6.56%	7.47%	1.54%	5.64%	3.68%	4.43%	7.95%	0.85%	-1.17%
Operating Income	368.67M	116.97M	78.59M	161.27M	157.80M	80.40M	130.48M	168.19M	191.11M	197.16M	224.64M	166.43M	143.09M	159.21M	156.25M	257.00M	172.08M	546.60M	14.86M	60.94M	-50.33M	32.06M	750.00K	8.74M	58.08M	-54.27M	-70.16M
Operating Income Ratio	8.05%	1.63%	1.07%	2.76%	3.26%	1.75%	3.47%	4.74%	5.96%	7.04%	7.57%	6.30%	5.45%	7.38%	9.24%	14.21%	9.58%	36.18%	3.33%	3.47%	-2.69%	1.71%	0.05%	0.72%	4.32%	-4.71%	-7.75%
Total Other Income/Expenses	-409.15M	-36.15M	-35.40M	-26.04M	-12.28M	-9.29M	-12.56M	-3.00M	-2.25M	-2.50M	-2.23M	-2.42M	-2.85M	-6.03M	-7.33M	-45.54M	-40.54M	-60.82M	-873.00K	8.80M	83.00M	18.41M	38.31M	14.36M	6.16M	0.00	12.62M
Income Before Tax	-40.49M	80.82M	43.19M	135.22M	145.52M	71.12M	117.92M	165.19M	188.87M	194.66M	222.40M	164.01M	140.24M	153.19M	148.92M	211.46M	131.54M	485.78M	13.99M	69.74M	32.67M	50.47M	39.06M	23.10M	64.24M	-54.27M	-57.54M
Income Before Tax Ratio	-0.88%	1.13%	0.59%	2.32%	3.01%	1.55%	3.14%	4.66%	5.89%	6.95%	7.49%	6.21%	5.34%	7.11%	8.81%	11.70%	7.33%	32.16%	3.14%	3.97%	1.74%	2.70%	2.58%	1.91%	4.78%	-4.71%	-6.36%
Income Tax Expense	-44.53M	24.92M	19.01M	25.08M	69.73M	42.41M	43.69M	39.92M	37.84M	65.04M	83.74M	57.34M	54.04M	58.67M	62.70M	82.41M	46.58M	33.81M	3.13M	36.39M	15.48M	27.38M	20.03M	9.24M	25.70M	-11.31M	-10.54M
Net Income	4.05M	55.90M	24.18M	110.14M	75.79M	28.71M	74.23M	125.26M	151.03M	129.62M	138.66M	106.67M	86.21M	94.52M	86.22M	129.05M	84.95M	451.97M	10.86M	33.35M	17.19M	23.10M	19.03M	13.86M	38.54M	-42.96M	-47.00M
Net Income Ratio	0.09%	0.78%	0.33%	1.89%	1.57%	0.62%	1.97%	3.53%	4.71%	4.63%	4.67%	4.04%	3.28%	4.38%	5.10%	7.14%	4.73%	29.92%	2.43%	1.90%	0.92%	1.23%	1.26%	1.14%	2.87%	-3.73%	-5.20%
EPS	0.16	2.28	0.97	4.72	3.27	1.15	2.78	4.63	5.51	4.25	4.10	3.03	2.18	2.43	2.33	3.59	2.40	12.80	0.31	1.00	0.53	0.73	0.62	0.47	1.24	-1.54	-1.78
EPS Diluted	0.16	2.28	0.97	4.51	3.14	1.11	2.71	4.53	5.42	4.17	4.03	3.01	2.16	2.37	2.23	3.42	2.34	10.86	0.26	0.81	0.53	0.72	0.61	0.46	1.24	-1.54	-1.78
Weighted Avg Shares Out	25.78M	24.56M	25.04M	23.33M	23.18M	24.87M	26.69M	27.05M	27.39M	30.48M	33.78M	35.25M	39.61M	38.94M	36.99M	35.97M	35.37M	35.31M	35.14M	33.45M	32.14M	31.76M	30.78M	29.47M	31.01M	27.87M	26.39M
Weighted Avg Shares Out (Dil)	25.78M	24.56M	25.04M	24.44M	24.16M	25.88M	27.36M	27.68M	27.88M	31.06M	34.44M	35.42M	40.00M	39.84M	38.62M	37.69M	36.36M	41.61M	41.44M	41.24M	32.39M	31.92M	31.20M	30.17M	31.01M	27.87M	26.39M

Magellan Federal Selected to Administer Military and Family Life Counseling Program for U.S. Department of Defense

March 18, 2021businesswire.com

PHOENIX--(BUSINESS WIRE)--Magellan Federal has been selected to serve as a contractor for the Military and Family Life Counseling Program for U.S. Department of Defense.

SHAREHOLDER ALERT: WeissLaw LLP Reminds APEX, MGLN, COHR, and FLIR Shareholders About Its Ongoing Investigations

March 16, 2021prnewswire.com

NEW YORK, March 16, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua...

ALERT: Halper Sadeh LLP Investigates MGLN, FFG, HMSY, FLIR; Shareholders are Encouraged to Contact the Firm

March 4, 2021prnewswire.com

NEW YORK, March 4, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Magellan Health, Inc. (NASDAQ: MGLN) concerning potential violations of the federal securities laws and/or breaches of fiduciary...

Magellan's (MGLN) Q4 Earnings Miss Estimates, Decline Y/Y

March 1, 2021zacks.com

Magellan Health's (MGLN) results reflect a decline in earnings and revenues due to lower contribution from Healthcare and Pharmacy Management units.

Magellan Health Reports 2020 Financial Results

February 26, 2021businesswire.com

PHOENIX--(BUSINESS WIRE)--Magellan Health has announced financial results for the fourth quarter and the year ended December 31, 2020.

INVESTIGATION ALERT: Halper Sadeh LLP Investigates TPCO, MGLN, WDR, TCF; Shareholders Are Encouraged to Contact the Firm

February 25, 2021globenewswire.com

NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

SHAREHOLDER ALERT: WeissLaw LLP Reminds MGLN, SMTX, FLIR, and TCF Shareholders About Its Ongoing Investigations

February 23, 2021prnewswire.com

NEW YORK, Feb. 23, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua...

Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - MGLN, BPFH, CMD, GWPH, SPWH, ALSK

February 12, 2021prnewswire.com

NEW YORK, Feb. 12, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Magellan Health, Inc. (NASDAQ: MGLN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties...

Mightier and Magellan Health Launch NIMH-Funded Research to Improve Outcomes in Children's Mental Health through the Use of Video Games

February 8, 2021prnewswire.com

24-month clinical study aims to understand how video games can improve the lives of children who suffer from a broad range of pediatric mental health disorders BOSTON, Feb. 8, 2021 /PRNewswire/ -- Mightier, provider of a ground-breaking video game system...